Walleye Capital LLC Anavex Life Sciences Corp. Put Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$4.55 - $6.75 $21,840 - $32,400	4,800 Added 22.54%	26,100 $132,000
Q4 2023 Feb 14, 2024	BUY	$5.04 - $9.95 $107,352 - $211,934	21,300 New	21,300 $198,000
Q2 2023 Aug 14, 2023	SELL	$7.66 - $9.5 $7,660 - $9,500	-1,000 Reduced 40.0%	1,500 $12,000
Q1 2023 May 15, 2023	BUY	$8.32 - $11.75 $20,800 - $29,375	2,500 New	2,500 $21,000

159

31.6M

910K

1.35M

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $321M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.